Switch to:
GuruFocus articles
Headlines from internet
Oct-19-17$50.02 (+0.99%)
08:00AMZacks Industry Outlook Highlights: Acorda Therapeutics, BioMarin Pharmaceutical, Valeant Pharmaceuticals International, Teva Pharmaceuticals and Sanofi Zacks
07:30AM3 Small-Cap Biotech Stocks That Could Be Big Winners in 2018 Fool
Oct-18-17$49.53 (-0.12%)
03:59PMPricing Pressure, Competition Remain Headwinds for Pharma Stocks Zacks
09:36AMHealthcare Dogfight Owens And Minor Edges Glaxosmithkline Top Broker Pick Gains October Seekingalpha
Oct-17-17$49.59 (-0.08%)
04:10PMMedicines Company May Best Investment 2017 Seekingalpha
09:48AMSanofi/Regeneron's Dupixent Succeeds in Phase II Study Zacks
Oct-16-17$49.63 (+0.28%)
12:54PMMannkind Corporation Can Afrezza Improved Labeling Fuel Successful Comeback Seekingalpha
11:42AMWall Street on Track to Close at Fresh Records as Energy Rises theStreet
11:21AMSanofi Upward Trajectory 2017 Seekingalpha
Oct-13-17$49.49 (-0.5%)
01:15AMA New FDA Approval Sends Small Cap Flexion Soaring Fool
Oct-12-17$49.74 (+0.02%)
06:18AMShould You Buy the Dip With MannKind Stock? Fool
Oct-11-17$49.73 (-0.74%)
12:17PMPfizer Consumer Sale Would Provide Loads of Options theStreet
12:05PMIs MannKind Corp Finally a Buy? Fool
Oct-10-17$50.1 (-0.63%)
09:00AMFlexion Could Draw Increased Takeover Interest After Drug Approval theStreet
Oct-09-17$50.42 (-0.3%)
03:05PMBiotech Forum Daily Digest Flexion Therapeutics Go Seekingalpha
09:00AM3 High-Yield Healthcare Stocks Fool
Oct-06-17$50.57 (-0.08%)
12:37PMUpdates Pcsk9 Inhibitor Legal Pipeline Scene Seekingalpha
12:05PMMannkind Race Win Seekingalpha
Oct-05-17$50.61 (+1.16%)
11:28AMHere's Why Alnylam Pharmaceuticals Rallied 32.7% in September Fool
Oct-02-17$49.77 (-0.04%)
05:19AMStarting Point Big Pharma Novartis Sanofi Clear Hurdles Seekingalpha
07:55AMWeek Review Another Billion Dollar Week China Life Science Deals Seekingalpha
Sep-29-17$49.79 (+0.79%)
07:48AMSanofi Worst Behind Seekingalpha
Sep-28-17$49.4 (-0.78%)
03:44PMGlaxosmithkline Get Ready Dividend Cut Pharma Giant Seekingalpha
Sep-25-17$49.97 (-0.74%)
12:04PMHurricane Lessons Seekingalpha
11:19AMAlnylam Sanofi Achieve Rnai First Seekingalpha
Sep-21-17$49.95 (+1.77%)
11:36AMDaily Pharma Scoop Intercepts Buy Opportunity Alcobras Downfall Shires Japanese Approval Seekingalpha
08:00AM3 Things Biotech Learn Today September 21 2017 Seekingalpha
Sep-20-17$49.08 (-0.04%)
11:04AMNanoflu Gives Novavax Room Maneuver Seekingalpha
Sep-18-17$48.64 (+0.43%)
01:36PMSanofi Sny Presents Bank America Merrill Lynch 2017 Global Healthcare Conference Slideshow Seekingalpha
10:10AMNovartis Value Creator Seekingalpha
Sep-14-17$48.72 (+0.43%)
08:55AMAmgen Needs Get Lucky Repatha Seekingalpha
Sep-13-17$48.51 (-0.66%)
11:35AMAblynx Catalyst Next Month Good Midterm Buy Seekingalpha
Sep-12-17$48.83 (+0.18%)
11:48AMRegenerons Frustrating Month Analysis Commentary Seekingalpha
04:31AM3 Dividend Superstars Strong Growth Potential Glaxosmithkline Pfizer Sanofi Seekingalpha
Sep-11-17$48.74 (-1.28%)
03:19PMOutlook Regenerons Potential Break Immune Checkpoint Inhibition Seekingalpha
08:00AM3 Things Biotech Learn Today September 9 2017 Seekingalpha
Sep-08-17$49.37 (+0.1%)
12:25PMVoyager Therapeutics Parkinsons Data Excites Wall Street Seekingalpha
Aug-25-17$48.7 (+0.56%)
09:48AMSanofi Takes A Multipronged Approach To Maintaining Its Dividend Performance Seekingalpha
Aug-23-17$48.24 (-0.45%)
10:57AMAlnylam: Q3 Catalysts Play Seekingalpha
Aug-22-17$48.46 (+0.5%)
05:13PMLigand: Situated For Growth Seekingalpha
Aug-21-17$48.22 (+0.06%)
12:33PMThe Troubles Never End For Teva Seekingalpha
Aug-14-17$47.73 (+0.38%)
12:15PMFibrogen And Galapagos Raise Lung Disease Hopes Seekingalpha
Aug-11-17$47.55 (+0.3%)
08:44AMMyoKardia's Strong Secondary Offering Flashes A Buy Signal Seekingalpha
07:28AMSanofi's Zika Standoff: Bad Medicine? Seekingalpha
Aug-10-17$47.41 (-0.71%)
10:07AMLooking Beyond Factors In Hemophilia Seekingalpha
Aug-09-17$47.75 (-0.35%)
03:39PMEsperion's Triple Combo Hits A Home Run Seekingalpha
03:25PMProLung Files For $8 Million Mini-IPO Seekingalpha
02:36PMDermira Grabs Big Pharma Castoff Seekingalpha
Aug-08-17$47.92 (-0.1%)
03:13PMDupixent Asthma Data Could Seal A Second Blockbuster Market Seekingalpha
12:53AMReassessing Regeneron Seekingalpha
Aug-07-17$47.97 (-0.23%)
08:19AMJohnson & Johnson Receives Massive 'No' From Panel: Hope Left? Seekingalpha
Aug-04-17$48.08 (+0.84%)
07:48AMSanofi Q2/2017: Mixed Signals Seekingalpha
Aug-03-17$47.68 (+0.42%)
07:56AMRead Read's Lips - No Deals Without U.S. Tax Reform Decision Seekingalpha
Jul-31-17$47.36 (-0.42%)
03:54PMSanofi 2017 Q2 - Results - Earnings Call Slides Seekingalpha
02:16PMAmgen Looks To Enhance Its Cholesterol Drug Seekingalpha
Jul-27-17$48.09 (+0.15%)
01:26PMThe 'Best Balance Sheets' Portfolio: LabCorp Seekingalpha
Jul-25-17$48.07 (+0.75%)
03:43PMSamsung Leaps Into Its First U.S. Biosimilars Battle Seekingalpha
09:00AM3 Things In Biotech You Should Learn Today: July 23, 2017 Seekingalpha
Jul-21-17$47.71 (-0.73%)
10:18AMSirukumab's Panel And U.S. Decision For Medicines Company Seekingalpha
Jul-19-17$46.81 (-1.95%)
02:09PMFDA's Flashing Green Light Boosts Novel Drug Approvals Seekingalpha
Jul-18-17$47.74 (-0.91%)
07:45AML'Oreal: Current Drop Might Be A Good Entry Position Seekingalpha
Jul-12-17$48.89 (+2.28%)
08:03AMMyoKardia Brings Hope To Hypertrophic Cardiomyopathy Seekingalpha
Jul-11-17$47.8 (+0.29%)
03:35PMSanofi Switches Eggs For Insects With Vaccines Move Seekingalpha
03:31PMGalafold Reversal Should Gladden Rare Disease Companies Seekingalpha
03:13PMAlnylam Buckles Down On A Belt Of Rare Diseases Seekingalpha
Jul-10-17$47.66 (-0.5%)
04:52PMAlnylam And Sanofi Produce Monster Alternative In Hemophilia Market Seekingalpha
09:01AM3 Things In Biotech You Should Learn Today: July 10, 2017 Seekingalpha
Jul-05-17$47.83 (+0.06%)
03:32PMSecond-Quarter Deals Show A Sector Set On Pause Seekingalpha
12:03PMA Look At Geron's Potential Myelofibrosis Competition Seekingalpha
Jun-30-17$47.91 (-0.52%)
02:12PMEuro Zone PMI At 5-Month Low: ETFs In Focus Seekingalpha
Jun-28-17$49.29 (+0%)
11:20AMComments On REVEAL, Merck's CTEP Inhibitor Study Seekingalpha
Jun-21-17$48.6 (+0.6%)
07:38AMAmicus Therapeutics: Elucidating The Bullish And Bearish Claims Seekingalpha
May-16-17$50.21 (+1.62%)
01:58PMCelgene Sales And Pipeline Keeping Pace With Expectations Seekingalpha
12:06PMRegeneron Will Still Be Heavily Reliant On Eylea Even If Sarilumab Becomes A Blockbuster Seekingalpha
May-10-17$49.67 (+1.14%)
09:03AMPieris Blooms With Astra Deal Seekingalpha
May-09-17$49.11 (+0.99%)
07:55AMMitsubishi Bags ALS Approval Without Radical Benefit Seekingalpha
May-05-17$49.12 (+0.33%)
03:44PMCould Dupixent Be To Regeneron What Sovaldi Was To Gilead? Seekingalpha
May-02-17$48.15 (+1.88%)
12:32PMSanofi: No Rush To Jump In After Q1 2017 Results Seekingalpha
07:55AM3 Things In Biotech You Should Learn Today: May 1, 2017 Seekingalpha
Apr-28-17$47.3 (+0.83%)
03:50PMSnippets Roundup: Sanofi Diabetes Disappointment, And Amgen Pullback Signals CGRP Caution Seekingalpha
10:07AMSanofi 2017 Q1 - Results - Earnings Call Slides Seekingalpha
Apr-27-17$46.91 (+1.06%)
02:08PMAmgen's Q1 Shows Challenges And Growth Opportunities Aplenty Seekingalpha
01:17PMG1 Therapeutics Seeks $115 Million IPO Seekingalpha
09:54AM3 Things In Biotech You Should Learn Today: April 28, 2017 Seekingalpha
04:37AMWingstop Over B-Dubs - Cramer's Lightning Round (4/26/17) Seekingalpha
Apr-26-17$46.42 (+0.04%)
09:59AM3 Things In Biotech You Should Learn Today: April 26, 2017 Seekingalpha
Apr-25-17$46.4 (+1.09%)
08:46AMMannkind Corporation Needs A Merger Seekingalpha
Apr-21-17$44.09 (-1.56%)
08:13AMMerck Leads Rivals In Novel Drug Approvals Seekingalpha
Apr-20-17$44.79 (+1.08%)
08:17PMProtalix BioTherapeutics Is Positioned Well For The Future Seekingalpha
Apr-12-17$45.39 (+0.49%)
12:31PMThreats And Opportunities In Atopic Dermatitis: What's Next For Sanofi And Regeneron? Seekingalpha
Apr-11-17$45.17 (+1.32%)
05:46PMCan Pluristem Therapeutics Corner The Acute Radiation Syndrome Market? Seekingalpha
Apr-07-17$44.81 (-1.1%)
05:59PMMannKind: White Elephant For Sale? Seekingalpha

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat